Summary
Global Oncology Nutrition Market to Reach $2.5 Billion by 2030
The global market for Oncology Nutrition estimated at US$1.2 Billion in the year 2022, is projected to reach a revised size of US$2.5 Billion by 2030, growing at a CAGR of 9.3% over the period 2022-2030. Head & Neck, one of the segments analyzed in the report, is projected to record 8.3% CAGR and reach US$609.6 Million by the end of the analysis period. Growth in the Stomach & Gastrointestinal segment is estimated at 11.5% CAGR for the next 8-year period.
The U.S. Market is Estimated at $443.3 Million, While China is Forecast to Grow at 11.3% CAGR
The Oncology Nutrition market in the U.S. is estimated at US$443.3 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$254.5 Million by the year 2030 trailing a CAGR of 11.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 7.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.
Select Competitors (Total 31 Featured)
- Abbott Laboratories, Inc.
- B. Braun Melsungen AG
- Koninklijke DSM N.V.
- Baxter International, Inc.
- Fresenius Kabi AG
- Fresenius SE & Co. KGaA
- Aceto Corporation
- Meiji Holdings Co., Ltd.
- Nestle Health Science SA
- Mead Johnson & Company, LLC.
- Nutricia BV
- Alniche Life Sciences Pvt., Ltd.
- Global Health Products, Inc.
- Pristine Organics Pvt. Ltd.
- Hexagon Nutrition
